Product
placebo-recFSH
1 clinical trial
1 indication
Indication
infertilityClinical trial
A Phase III, Randomized, Double-blind, Active-controlled, Equivalence Clinical Trial to Investigate the Efficacy and Safety of a Single Injection of 100 µg Org 36286 (Corifollitropin Alfa) to Induce Multifollicular Development for Controlled Ovarian Stimulation (COS) Using Daily Recombinant FSH (recFSH) as a ReferenceStatus: Completed, Estimated PCD: 2007-07-07